Evaluating systemic lupus erythematosus disease activity using molecular markers of hemostasis

Arthritis and Rheumatism

Volumn 39, Issue 2, 1996, Pages 287-291

  Inoh, Masayuki ^a   Tokuda, Michiaki ^a   Kiuchi, Hiroyuki ^a   Kurata, Noriyuki ^a   Takahara, Jiro ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPLASMIN; ANTITHROMBIN III; FIBRIN; FIBRIN DEGRADATION PRODUCT; MONOCLONAL ANTIBODY; PLASMIN; THROMBIN;

ADULT; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; ANTITHROMBIN III; BETAMETHASONE; BIOLOGICAL MARKERS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMOSTASIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHYLPREDNISOLONE; PARTIAL THROMBOPLASTIN TIME; PEPTIDE HYDROLASES; PLASMIN; PROTHROMBIN TIME;

EID: 0030045215     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390217     Document Type: Article

References (20)

1. Steinberg AD, Gourley MF, Klinman DM, Tsokos GC, Scott DE, Krieg AM: Sytemic lupus erythematosus. Ann Intern Med 115:548-559, 1991
2. Philips MR, Abramson SB, Weissmann G: Neutrophil adhesion and autoimmune vascular injury. Clin Aspects Autoimmun 3:6-15, 1989
3. Shinichi O, Shogo T, Nobuo A: Plasma thrombomodulin as a marker of vascular injuries in collagen vascular disease. Am J Clin Pathol 101:109-113, 1994
4. Pelzer H, Egbring R, Seitz R, Blanke H, Heinburger N: Thrombin-antithrombin III complex: a new parameter for detection of thrombotic states. Thromb Haemost 58:237-238, 1987
5. Rylatt DB, Blake AS, Cottis LE, Massingham DA, Fletcher WA, Masci PP, Whitaker AN, Elms M, Bunce I, Webber AJ, Wyatt D, Bundesen PG: An immunoassay for human D-dimer using monoclonal antibodies. Thromb Res 31:767-778, 1983
6. 2-plasmin inhibitor. Blood 69:446-453, 1987
7. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rotnfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271-1277, 1982
8. Astedt B, Isacson S, Nilsson IM, Pandolfi M: Thrombosis and oral contraceptives: possible predisposition. Br Med J 4:631-634, 1979
9. Taki M, Ikeda Y, Handa M, Yamamoto M, Watanabe K, Matsuo S, Meguro T,Yamada K: Role of antiphospholipid antibodies in the pathogenesis of thrombosis in antiphospholipid syndrome. Acta Hematol Jap 53:1620-1629, 1990
10. Ginsberg JS, Demers C, Brill-Edwards P, Johnston M, Bona R, Burrows RF, Weitz J, Denburg JA: Increased tnrombin generation and activity in patients with systemic lupus erythematosus and anticardiolipin antibodies: evidence for a prothrombotic state. Blood 11:2958-2963, 1993
11. Vogel JJ, Reber G, de Moerloose P: Laboratory and clinical features in systemic lupus erythematosus patients with or without anticardiolipin antibodies. Thromb Res 62:545-556, 1991
12. Takeda H: Effects of glycosylated serum proteins on prostaglandin synthesis in platelets and vascular endothelial cells. In, Recent Advances in Insulin Therapy. Edited by TH Lee. Amsterdam, Excerpta Medica, 1990
13. Sumdell JB, Nilson TK, Hollmans G, Hellsten G, Dahlen GH: Interrelationship between plasma level of plasminogen activation inhibitor, tissue plasminogen activator, lipoprotein (a) and established cardiovascular risk factors in a north Swedish population. Atherosclerosis 80:9-16, 1989
14. Schleiffer T, Hellstem P, Freitag M, Brass H: Plasminogen activator inhibitor 1 activity and lipoprotein (a) in nephropathic patients with non-insulin-dependent diabetes mellitus versus patients with nondiabetic nephropathy. Haemostasis 24:49-54, 1994
15. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE: Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35:630-640, 1992
16. Langdell PD, Wagner RH, Brinkhous KM: Effect of antihemophilic factor on one-stage clotting time. J Lab Clin Med 47:637-639, 1953
17. Quick AJ, Brown MS, Bancroft FW: A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 190:501-503, 1953
18. Bauer KA, Rosenberg RD: The pathophysiology of the prethrombotic state in humans: insights gained from studies using markers of hemostatic system activation. Blood 70:343-347, 1987
19. Stern D, Nawroth P, Handley D, Kisiel W: An endothelial cell-dependent pathway of coagulation. Proc Natl Acad Sci U S A 82:2523-2527, 1985
20. Cotran RS: New roles for the endothelium in inflammation and immunity. Am J Pathol 129:407-413, 1987